My NCBI | Sign In
RSS Settings
  • Search: Crossey PA[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 22

    1.

    Effect of endothelium-specific insulin resistance on endothelial function in vivo.

    Duncan ER, Crossey PA, Walker S, Anilkumar N, Poston L, Douglas G, Ezzat VA, Wheatcroft SB, Shah AM, Kearney MT.

    Diabetes. 2008 Dec;57(12):3307-14. Epub 2008 Oct 3. Erratum in: Diabetes. 2009 Feb;58(2):511. Kearney, Mark I [correct to Kearney, Mark T]. PMID: 18835939 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    IGF-binding protein-2 protects against the development of obesity and insulin resistance.

    Wheatcroft SB, Kearney MT, Shah AM, Ezzat VA, Miell JR, Modo M, Williams SC, Cawthorn WP, Medina-Gomez G, Vidal-Puig A, Sethi JK, Crossey PA.

    Diabetes. 2007 Feb;56(2):285-94.PMID: 17259371 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor.

    Wheatcroft SB, Shah AM, Li JM, Duncan E, Noronha BT, Crossey PA, Kearney MT.

    Diabetes. 2004 Oct;53(10):2645-52.PMID: 15448096 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1.

    Wheatcroft SB, Kearney MT, Shah AM, Grieve DJ, Williams IL, Miell JP, Crossey PA.

    Diabetes. 2003 Aug;52(8):2075-82.PMID: 12882925 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice.

    Crossey PA, Pillai CC, Miell JP.

    J Clin Invest. 2002 Aug;110(3):411-8.PMID: 12163461 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance.

    Crossey PA, Jones JS, Miell JP.

    Diabetes. 2000 Mar;49(3):457-65.PMID: 10868969 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease.

    Holt RI, Crossey PA, Jones JS, Baker AJ, Portmann B, Miell JP.

    Hepatology. 1997 Dec;26(6):1600-6.PMID: 9398004 [PubMed - indexed for MEDLINE]Related articles

    8.

    Differential effects of malnutrition, bile duct ligation and galactosamine injection in young rats on serum levels and gene expression of IGF-binding proteins.

    Holt RI, Baker AJ, Jones JS, Crossey PA, Stone NM, Preedy VR, Miell JP.

    J Endocrinol. 1996 Jun;149(3):465-72.PMID: 8691105 [PubMed - indexed for MEDLINE]Related articles

    9.

    Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.

    Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT.

    J Med Genet. 1996 Apr;33(4):328-32.PMID: 8730290 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.

    Ritter MM, Frilling A, Crossey PA, Höppner W, Maher ER, Mulligan L, Ponder BA, Engelhardt D.

    J Clin Endocrinol Metab. 1996 Mar;81(3):1035-7.PMID: 8772572 [PubMed - indexed for MEDLINE]Related articles

    11.

    Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

    Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson-Smith MA, Brauch H, Glavac D, Neumann HP, Tisherman S, Mulvihill JJ, Gross DJ, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard S, Lips CH, Lerman M, et al.

    Hum Mutat. 1996;8(4):348-57.PMID: 8956040 [PubMed - indexed for MEDLINE]Related articles

    12.

    Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

    Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PL, O'Riordan JL, Toledo SP, et al.

    J Med Genet. 1995 Dec;32(12):934-7.PMID: 8825918 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.

    Crossey PA, Eng C, Ginalska-Malinowska M, Lennard TW, Wheeler DC, Ponder BA, Maher ER.

    J Med Genet. 1995 Nov;32(11):885-6.PMID: 8592333 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.

    Neumann HP, Eng C, Mulligan LM, Glavac D, Zäuner I, Ponder BA, Crossey PA, Maher ER, Brauch H.

    JAMA. 1995 Oct 11;274(14):1149-51.PMID: 7563486 [PubMed - indexed for MEDLINE]Related articles

    15.

    Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

    Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, et al.

    Hum Mol Genet. 1994 Dec;3(12):2169-73.PMID: 7881415 [PubMed - indexed for MEDLINE]Related articles

    16.

    Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.

    Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA, et al.

    Hum Mol Genet. 1994 Aug;3(8):1303-8.PMID: 7987306 [PubMed - indexed for MEDLINE]Related articles

    17.

    Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene.

    Richards FM, Crossey PA, Phipps ME, Foster K, Latif F, Evans G, Sampson J, Lerman MI, Zbar B, Affara NA, et al.

    Hum Mol Genet. 1994 Apr;3(4):595-8.PMID: 8069305 [PubMed - indexed for MEDLINE]Related articles

    18.

    Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22.

    Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, Bentley E, Affara NA, Ferguson-Smith MA, Maher ER.

    Br J Cancer. 1994 Feb;69(2):230-4.PMID: 8297719 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours.

    Crossey PA, Foster K, Richards FM, Phipps ME, Latif F, Tory K, Jones MH, Bentley E, Kumar R, Lerman MI, et al.

    Hum Genet. 1994 Jan;93(1):53-8.PMID: 8270255 [PubMed - indexed for MEDLINE]Related articles

    20.

    Mapping the Von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis.

    Richards FM, Phipps ME, Latif F, Yao M, Crossey PA, Foster K, Linehan WM, Affara NA, Lerman MI, Zbar B, et al.

    Hum Mol Genet. 1993 Jul;2(7):879-82.PMID: 8364570 [PubMed - indexed for MEDLINE]Related articles

    21.

    Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus.

    Crossey PA, Maher ER, Jones MH, Richards FM, Latif F, Phipps ME, Lush M, Foster K, Tory K, Green JS, et al.

    Hum Mol Genet. 1993 Mar;2(3):279-82.PMID: 8499917 [PubMed - indexed for MEDLINE]Related articles

    22.

    Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene.

    Richards FM, Maher ER, Latif F, Phipps ME, Tory K, Lush M, Crossey PA, Oostra B, Enblad P, Gustavson KH, et al.

    J Med Genet. 1993 Feb;30(2):104-7. Erratum in: J Med Genet 1993 Jun;30(6):528. PMID: 8445612 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    6 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity